Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

345 ARTÍCULOS , VIENDO DEL 136 AL 150

Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology

Revett TJ, Baker GB, Jhamandas J, Kar S.

J Psychiatry Neurosci. 2013 Jan;38(1):6-23. doi: 10.1503/jpn.110190.

Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease

Zhong Y, Zheng X, Miao Y, Wan L, Yan H, Wang B.

Am J Med Sci. 2013 Mar;345(3):222-6. doi: 10.1097/MAJ.0b013e318255a8f9.

Potential immunotargets for Alzheimer's disease treatment strategies

Fernández PL, Britton GB, Rao KS.

J Alzheimers Dis. 2013;33(2):297-312. doi: 10.3233/JAD-2012-121222.

Immunotherapy against amyloid pathology in Alzheimer's disease

Galimberti D, Ghezzi L, Scarpini E.

J Neurol Sci. 2013 Oct 15;333(1-2):50-4. doi: 10.1016/j.jns.2012.12.013. Epub 2013 Jan 5.

Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?

Aisen PS, Vellas B.

J Nutr Health Aging. 2013 Jan;17(1):49-50. doi: 10.1007/s12603-013-0001-3.

Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells

Wojda U, Kuznicki J.

J Alzheimers Dis. 2013;34(3):563-88. doi: 10.3233/JAD-121984.

Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer disease

Burstein AH, Zhao Q, Ross J, Styren S, Landen JW, Ma WW, McCush F, Alvey C, Kupiec JW, Bednar MM.

Clin Neuropharmacol. 2013 Jan-Feb;36(1):8-13. doi: 10.1097/WNF.0b013e318279bcfa.

Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study

Landen JW, Zhao Q, Cohen S, Borrie M, Woodward M, Billing CB Jr, Bales K, Alvey C, McCush F, Yang J, Kupiec JW, Bednar MM.

Clin Neuropharmacol. 2013 Jan-Feb;36(1):14-23. doi: 10.1097/WNF.0b013e31827db49b.

Dementia in 2012: Further insights into Alzheimer disease pathogenesis

Weiner MW.

Nat Rev Neurol. 2013 Feb;9(2):65-6. doi: 10.1038/nrneurol.2012.275. Epub 2013 Jan 22.

Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors

Martinelli-Boneschi F, Giacalone G, Magnani G, Biella G, Coppi E, Santangelo R, Brambilla P, Esposito F, Lupoli S, Clerici F, Benussi L, Ghidoni R, Galimberti D, Squitti R, Confaloni A, Bruno G, Pichler S, Mayhaus M, Riemenschneider M, Mariani C, Comi G, Scarpini E, Binetti G, Forloni G, Franceschi M, Albani D.

Neurobiol Aging. 2013 Jun;34(6):1711.e7-13. doi: 10.1016/j.neurobiolaging.2012.12.008. Epub 2013 Jan 29.

Aluminum involvement in the progression of Alzheimer's disease

Walton JR.

J Alzheimers Dis. 2013;35(1):7-43. doi: 10.3233/JAD-121909.

[Nitrergic cerebrovascular regulation as affected by donepezil]

Toda N.

Nihon Yakurigaku Zasshi. 2013 Mar;141(3):150-4. doi: 10.1254/fpj.141.150.

Slow excitotoxicity in Alzheimer's disease

Ong WY, Tanaka K, Dawe GS, Ittner LM, Farooqui AA.

J Alzheimers Dis. 2013;35(4):643-68. doi: 10.3233/JAD-121990.

Alzheimer's disease and insulin resistance: translating basic science into clinical applications

De Felice FG.

J Clin Invest. 2013 Feb;123(2):531-9. doi: 10.1172/JCI64595. Epub 2013 Feb 1.

Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology

Hochgräfe K, Sydow A, Mandelkow EM.

FEBS J. 2013 Sep;280(18):4371-81. doi: 10.1111/febs.12250. Epub 2013 Apr 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias